The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis
- 15 January 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 23 (2), 379-385
- https://doi.org/10.1038/sj.onc.1207074
Abstract
Mounting genetic evidence suggests that each product of the Ink4a/Arf locus, p16INK4a and p19ARF, possesses tumor-suppressor activity (Kamijo et al., 1997; Krimpenfort et al., 2001; Sharpless et al., 2001a). We report the generation and characterization of a p19ARF-specific knockout allele (p19ARF−/−) and direct comparison with mice and derivative cells deficient for p16INK4a, both p16INK4a and p19ARF, and p53. Like Ink4a/Arf−/− murine embryo fibroblasts (MEFs), p19ARF−/− MEFs were highly susceptible to oncogenic transformation, exhibited enhanced subcloning efficiency at low density, and resisted both RAS- and culture-induced growth arrest. In contrast, the biological profile of p16INK4a−/− MEFs in these assays more closely resembled that of wild-type cells. In vivo, however, both p19ARF−/− and p16INK4a−/− animals were significantly more tumor prone than wild-type animals, but each less so than p53−/− or Ink4a/Arf−/− animals, and with differing tumor spectra. These data confirm the predominant role of p19ARF over p16INK4a in cell culture-based assays of MEFs, yet also underscore the importance of the analysis of tumor suppressors across many cell types within the organism. The cancer-prone conditions of mice singly deficient for either p16INK4a or p19ARF agree with data derived from human cancer genetics, and reinforce the view that both gene products play significant and nonredundant roles in suppressing malignant transformation in vivo.Keywords
This publication has 36 references indexed in Scilit:
- Biallelic Mutations in p16INK4a Confer Resistance to Ras- and Ets-Induced Senescence in Human Diploid FibroblastsMolecular and Cellular Biology, 2002
- INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescenceThe EMBO Journal, 2002
- Constitutive telomerase expression promotes mammary carcinomas in aging miceProceedings of the National Academy of Sciences, 2002
- Germline mutation of ARF in a melanoma kindred.Human Molecular Genetics, 2002
- Epidermal growth factor receptor and Ink4a/ArfCancer Cell, 2002
- Dual Inactivation of RB and p53 Pathways in RAS-Induced MelanomasMolecular and Cellular Biology, 2001
- Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivationOncogene, 1998
- Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island MethylationMolecular and Cellular Biology, 1998
- Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Germline p16 mutations in familial melanomaNature Genetics, 1994